Effect of c-Met inhibitor SU11274 on hepatocellular carcinoma cell growth

ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity

(2010) N. Munshi et al.   MOLECULAR CANCER THERAPEUTICS

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

(2010) S Whittaker et al.   ONCOGENE

Significance of Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy

(2009) Kentaroh Yamamoto et al.   ANNALS OF SURGICAL ONCOLOGY

E7050: A dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models

(2009) Takayuki Nakagawa et al.   CANCER SCIENCE

Down-Regulation of c-Met Expression Inhibits Human HCC Cells Growth and Invasion by RNA Interference

(2009) Bin Xie et al.   JOURNAL OF SURGICAL RESEARCH

Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells

(2008) Fu-Jun Gao et al.   LIFE SCIENCES